Wow what wonderful wirlitzerationWirtz is worth the wait.
Wow what wonderful wirlitzerationWirtz is worth the wait.
The point is, market cap is moved by financial reports. They are noting huge extraordinary expenses, cash reserves have fallen, and the outlook for sales isn't great. Carefully scoring 100m by realising an asset or two from non-core business is serious stuff.Pretty sure Bayer Pharmaceuticals' €50bn market cap won't be moved by the transfer dealings of the football club.
For reference purposes, a potential €100m deal for Wirtz is less than one day's revenue for Bayer AG.
Fancy a bet Paqueta is your manI'm wondering if he may be reunited with Alonso at City in a couple of years time.
Just a guess but I'd be tempted to have a quid on at a big price.
Why are people so sure we have no chance to get him this summer? Maybe there's something I'm missing. If we were willing to pay 80M for Paqueta and 90M for Rice then we can and should pay 100M for a tremendous talent like Wirtz. Besides, why don't we offer them McAtee in exchange for a loan? It's a win-win situation for all parties. I would even send Oscar Bobb there to get minutes.
100M in anyone's books is not to be sniffed at.The point is, market cap is moved by financial reports. They are noting huge extraordinary expenses, cash reserves have fallen, and the outlook for sales isn't great. Carefully scoring 100m by realising an asset or two from non-core business is serious stuff.
Have a read of the 23h1 interim statement and tell me these guys aren't under pressure;
Core earnings per share at €1.22
(– 36.8%)
// Net income at minus €1.9 billion,
weighed down by impairment losses
of €2.3 billion
// Free cash flow at minus €0.5 billion
// Group outlook for 2023 lowered
fingers crossed100M in anyone's books is not to be sniffed at.
A deal will be done if we are willing to pay the price.